Anya Sahni is an illustrator and was The Transmitter’s art intern in the summer of 2024. She is an undergraduate student at Rensselaer Polytechnic Institute, where she studies neuroscience and art.
Anya Sahni
Art intern
The Transmitter
From this contributor
Thinking about thinking: AI offers theoretical insights into human memory
We need a new conceptual framework for understanding cognitive functions—particularly how globally distributed brain states are formed and maintained for hours.
Thinking about thinking: AI offers theoretical insights into human memory
By
Terrence Sejnowski
5 May 2025 | 7 min read
Revisiting sex and gender in the brain
To conduct scientifically accurate and socially responsible research, it is useful to think of “sex” as a complex, multifactorial and context-dependent variable.
Revisiting sex and gender in the brain
By
Marija Kundakovic
28 January 2025 | 8 min read
Say what? The Transmitter’s top quotes of 2024
“We’ve cured mouse-heimer’s thousands of times...”—find out who said this to a Transmitter reporter, and read our other favorite quotes from the past year.
Say what? The Transmitter’s top quotes of 2024
By
The Transmitter
23 December 2024 | 2 min read
Neural manifolds: Latest buzzword or pathway to understand the brain?
When you cut away the misconceptions, neural manifolds present a conceptually appropriate level at which systems neuroscientists can study the brain.
Neural manifolds: Latest buzzword or pathway to understand the brain?
By
Matthew Perich
2 October 2024 | 8 min read
Ketamine targets lateral habenula, setting off cascade of antidepressant effects
The drug’s affinity for overactive cells in the “anti-reward” region may help explain its rapid and long-lasting results.
Ketamine targets lateral habenula, setting off cascade of antidepressant effects
By
Olivia Gieger
4 September 2024 | 6 min read
Explore more from The Transmitter
‘Overdue’ debate unfurls over neuroimaging method
After a January paper questioned the validity of an approach called lesion network mapping, its users are pressure testing their results.
‘Overdue’ debate unfurls over neuroimaging method
After a January paper questioned the validity of an approach called lesion network mapping, its users are pressure testing their results.
By
Angie Voyles Askham
17 April 2026 | 8 min read
Nearly 400 compounds affect behaviors tied to autism-linked genes in zebrafish
Estropipate, paclitaxel and levocarnitine altered behaviors tied to SCN2A and DYRK1A variants specifically, a new open-source platform revealed.
Nearly 400 compounds affect behaviors tied to autism-linked genes in zebrafish
Estropipate, paclitaxel and levocarnitine altered behaviors tied to SCN2A and DYRK1A variants specifically, a new open-source platform revealed.
By
Charles Q. Choi
16 April 2026 | 4 min read
What neuroscientists want from a new NINDS director
The search is underway for the next director of the U.S. National Institute of Neurological Disorders and Stroke, who will face a range of challenges, neuroscientists say, but will also have an “immense opportunity to do good things.”
What neuroscientists want from a new NINDS director
The search is underway for the next director of the U.S. National Institute of Neurological Disorders and Stroke, who will face a range of challenges, neuroscientists say, but will also have an “immense opportunity to do good things.”
By
Helena Kudiabor
15 April 2026 | 4 min read